Multiplex Assay Kit for Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD105; END; HHT1; ORW; ORW1; Osler-Rendu-Weber Syndrome 1

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-89 85
EDTA plasma(n=5) 88-101 92
heparin plasma(n=5) 81-98 92

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-98% 78-99% 83-102% 90-99%
EDTA plasma(n=5) 84-98% 90-103% 98-105% 83-101%
heparin plasma(n=5) 91-99% 91-102% 97-105% 79-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:ENG) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clin Rev Allergy Immunol Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature PubMed: 26142066
Angiologia e Cirurgia Vascular Peripheral vasculopathy in Raynaud phenomenon: Vascular disease biomarkers science:S1646706X16300052
Clinical Rheumatology Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis Pubmed:26920752
Advanced Biomedical Research Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia pubmed:27563629
Annals of agricultural and environmental medicine Relationships between serum selenium and zinc concentrations versus profibrotic and proangiogenic cytokines (FGF-19 and endoglin) in patients with alcoholic liver cirrhosis. pubmed:28954507
ResearchSquare The predictive role of PlGF/sENG ratio in fetal growth restriction of early beginning associated with pre-eclampsia
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA980Hu01 Recombinant Endoglin (ENG) Positive Control; Immunogen; SDS-PAGE; WB.
RPA980Hu03 Recombinant Endoglin (ENG) Positive Control; Immunogen; SDS-PAGE; WB.
RPA980Hu02 Recombinant Endoglin (ENG) Positive Control; Immunogen; SDS-PAGE; WB.
PAA980Hu01 Polyclonal Antibody to Endoglin (ENG) WB; IHC; ICC; IP.
PAA980Hu02 Polyclonal Antibody to Endoglin (ENG) WB; IHC; ICC; IP.
FAA980Hu01 Anti-Endoglin (ENG) Polyclonal Antibody FCM
LAA980Hu71 Biotin-Linked Polyclonal Antibody to Endoglin (ENG) WB; IHC; ICC.
MAA980Hu22 Monoclonal Antibody to Endoglin (ENG) WB; IHC; ICC; IP.
MAA980Hu21 Monoclonal Antibody to Endoglin (ENG) WB; IHC; ICC; IP.
FAA980Hu52 APC-Linked Anti-Endoglin (ENG) Monoclonal Antibody FCM
FAA980Hu82 FITC-Linked Anti-Endoglin (ENG) Monoclonal Antibody FCM
SEA980Hu ELISA Kit for Endoglin (ENG) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA980Hu Multiplex Assay Kit for Endoglin (ENG) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA980Hu01 ELISA Kit DIY Materials for Endoglin (ENG) Main materials for "Do It (ELISA Kit) Yourself".